Premium
Oruka Therapeutics Inc (ORKA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Dr. Carl Linden DambkowskiIndependent Director | -42,74k | 2,54M | Automatic Disposition | 59,10 - 59,97 | 73,74k | -36,69% |
| 2026-05-21 | Dr. Carl Linden DambkowskiIndependent Director | -62,26k | 3,16M | Derivative Exercise and Sale | 6,84 - 59,10 | 73,74k | - |
| 2026-05-18 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -2,46k | 147,72k | Automatic Disposition | 59,19 - 61,16 | 16,41k | -13,03% |
| 2026-05-18 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -7,83k | 234,49k | Derivative Exercise and Sale | 12,50 - 59,19 | 16,41k | - |
| 2026-05-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 381,70k | Derivative Exercise and Sale | 6,84 - 63,52 | 33,38k | - |
| 2026-05-01 | Ms. Laura SandlerCOO | -5,00k | 280,38k | Derivative Exercise and Sale | 7,80 - 68,48 | 236,98k | - |
| 2026-04-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 411,59k | Derivative Exercise and Sale | 6,84 - 67,38 | 33,38k | - |
| 2026-03-16 | Dr. Lawrence Otto KleinPresident, CEO & Director | -1,73k | 71,41k | Vente | 41,30 | 927,31k | -0,19% |
| 2026-03-16 | Mr. Arjun AgarwalSenior VP of Finance & Treasurer | -395,00 | 16,31k | Vente | 41,30 | 18,86k | -2,05% |
| 2026-03-16 | Ms. Laura SandlerCOO | -600,00 | 24,78k | Vente | 41,30 | 236,98k | -0,25% |
| 2026-03-16 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 234,85k | Derivative Exercise and Sale | 6,84 - 41,94 | 33,38k | - |
| 2026-03-16 | Dr. Joana GoncalvesChief Medical Officer | -641,00 | 26,47k | Vente | 41,30 | 33,38k | -1,88% |
| 2026-03-16 | Mr. Paul T. QuinlanGeneral Counsel & Secretary | -733,00 | 30,27k | Vente | 41,30 | 31,77k | -2,26% |
| 2026-03-02 | Ms. Laura SandlerCOO | -5,00k | 128,82k | Derivative Exercise and Sale | 7,80 - 33,81 | 237,58k | - |
| 2026-02-17 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 175,32k | Derivative Exercise and Sale | 6,84 - 32,78 | 34,02k | - |
| 2026-01-15 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 171,46k | Derivative Exercise and Sale | 6,84 - 32,24 | 1,52k | - |
| 2026-01-02 | Ms. Laura SandlerCOO | -5,00k | 101,83k | Derivative Exercise and Sale | 7,80 - 28,17 | 205,08k | - |
| 2026-01-02 | Ms. Laura SandlerCOO | -8,00k | 229,97k | Automatic Disposition | 28,17 - 29,75 | 205,08k | -3,75% |
| 2025-12-19 | Dr. Joana GoncalvesChief Medical Officer | -7,00k | 163,05k | Derivative Exercise and Sale | 6,84 - 31,58 | 1,52k | - |
| 2025-09-17 | Fairmount Funds Management LLCSociété | 333,34k | 5,00M | Achat | 15,00 | 3,71M | 9,89% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
